Historical record - last NADAC effective date: 8/17/2016
Product Information
ZIANA GEL is a brand product labeled by Bausch Health US LLC, priced at $11.4072 per GM under NDC 99207030060. Its NADAC has been published 195 times since Nov 28, 2013.
FDA first approved this application on Nov 7, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the clindamycin phosphate and tretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12; .25 mg/g; mg/g
Manufacturer
Bausch Health US LLCNDC
99207030060
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/17/2016
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA050802FDA Approved
11/7/2006
TE Code
AB1
On Market Since
12/1/2006
Pharmacological Classes
Price Statistics
The NADAC for ZIANA GEL has been published 195 times since Nov 28, 2013, and over the history we have for it it has risen 27.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4072 per GM |
|---|---|
| All-time high | $11.4072 (Aug 16, 2017) |
| All-time low | $8.9775 (Nov 28, 2013) |
| Median price | $11.2462 |
| Average price | $10.9764 |
| Largest weekly change | +15.0% (Jan 15, 2014) |
| Weeks tracked | 195 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+27.1%
Last surveyed Aug 16, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate and tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZIANA GEL?
The current National Average Drug Acquisition Cost (NADAC) for ZIANA GEL, manufactured by Bausch Health US LLC, is $11.4072 per GM (NDC 99207030060), effective Aug 16, 2017.
How has the price of ZIANA GEL changed over time?
Over the history we have for it, the NADAC for ZIANA GEL has risen 27.1%. It has been tracked across 195 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIANA GEL?
Since Nov 28, 2013, the NADAC for ZIANA GEL has ranged from a low of $8.9775 (Nov 28, 2013) to a high of $11.4072 (Aug 16, 2017), with a median of $11.2462 per GM.
Are there cheaper alternatives to ZIANA GEL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDA-TRETINOIN 1.2%-0.025%, is $4.3997 per GM — about 61% below ZIANA GEL.
Who manufactures ZIANA GEL?
ZIANA GEL (NDC 99207030060) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.